Innate Pharma announces launch of proposed global offering and Nasdaq listing
07 oct. 2019 01h00 HE
|
INNATE PHARMA
Marseille, France, October 7, 2019, 7:00 CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...